Acth and Sluggishness - a phase IV clinical study of FDA data

Summary:

Sluggishness is reported as a side effect among people who take Acth (corticotropin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin E, and have Dermatomyositis.

The phase IV clinical study analyzes which people have Sluggishness when taking Acth. It is created by eHealthMe based on reports of 5,384 people who have side effects when taking Acth from the FDA, and is updated regularly.

What is Acth?

Acth has active ingredients of corticotropin. eHealthMe is studying from 5,402 Acth users. Check the latest studies of Acth.

What is Sluggishness?

Sluggishness (lacking alertness) is found to be associated with 871 drugs and 740 conditions by eHealthMe. Check the latest studies of Sluggishness.

On Jan, 10, 2026

5,384 people reported to have side effects when taking Acth.
Among them, 18 people (0.33%) have Sluggishness.

Among these 18 people:

How long have people been on Acth when they have Sluggishness? *

What is the gender of people who have Sluggishness when taking Acth? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Sluggishness when taking Acth? *

What are other drugs people take besides Acth? *

What are other side effects people have besides Sluggishness? *

Pain: 12 people, 66.67%
Fatigue (feeling of tiredness): 11 people, 61.11%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 27.78%
Joint Pain: 5 people, 27.78%
Drowsiness: 5 people, 27.78%
Nausea (feeling of having an urge to vomit): 5 people, 27.78%
Abdominal Discomfort: 4 people, 22.22%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 4 people, 22.22%
Haemoglobin Decreased: 4 people, 22.22%
Gait Disturbance: 4 people, 22.22%

What are the existing conditions these people have? *

Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 5 people, 27.78%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 5 people, 27.78%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 22.22%
Haemoglobin Decreased: 4 people, 22.22%
Back Pain: 3 people, 16.67%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
Skin Blushing/flushing (a sudden reddening of the face, neck): 1 person, 5.56%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.56%
Pulmonary Sarcoidosis (growth of tiny collections of inflammatory cells in lungs): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Acth and have Sluggishness?

- Check whether Sluggishness is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acth:

Acth (5,402 reports)

Sluggishness treatments and more:

Sluggishness (11,737 reports)

Browse all side effects of Acth:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sluggishness:

Sluggishness (870 drugs)

Browse all the conditions that are associated with Sluggishness:

Sluggishness (740 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acth) and Acth (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.